What is the current market size?

The Built-in Gastric Balloon market size was valued at USD 1.2 billion in 2023, driven by increasing obesity prevalence and demand for non-invasive weight loss solutions.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by advancements in medical technology and rising healthcare investments in Asia-Pacific regions.

What are the key growth drivers?

Key drivers include rising obesity rates, growing preference for non-surgical interventions, and innovations in balloon design for improved patient outcomes and safety.

What challenges does the market face?

Challenges include stringent regulatory requirements, high treatment costs, and competition from alternative weight management therapies like bariatric surgery.

Which regions are leading the market?

North America is the dominant market, followed by Europe and the Asia-Pacific region, due to advanced healthcare infrastructure and higher obesity rates.

Who are the top companies in the market?

Leading companies include Apollo Endosurgery, Medtronic, and Bariatric Solutions, Inc., known for their innovative product portfolios and strong global distribution networks.

What future opportunities exist for this market?

Emerging markets in Latin America and the Middle East offer growth potential, alongside opportunities in telehealth integration and personalized treatment solutions.

How is technology impacting the market?

Advances in biodegradable materials, AI-guided placement systems, and real-time monitoring technologies are enhancing precision and reducing procedure risks.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA require rigorous clinical trials for approval, ensuring safety and efficacy while creating barriers for new market entrants.

Built-in Gastric Balloon Market Growth Drivers & Forecast 2033

Built-in Gastric Balloon by Application (Hospital, Clinic, Other), by Types (Plastic, Polymer Materials, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Built-in Gastric Balloon Market Size | CAGR 2019 Forecast 2033

Built-in Gastric Balloon Market Growth Drivers & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Built-in Gastric Balloon Market Overview

The Built-in Gastric Balloon market represents a segment of the weight management industry focused on non-surgical, endoscopic devices designed to reduce stomach volume and promote satiety. Its relevance lies in addressing the growing demand for minimally invasive obesity treatments amid rising global health concerns. The Built-in Gastric Balloon market size is projected to reflect robust growth outlook through 2033, driven by advancements in medical technology and increasing adoption of outpatient procedures. This market forecast underscores its strategic importance in the broader industry expansion of medical devices.

The global Built-in Gastric Balloon market size was estimated at $420 million in 2025, with a compound annual growth rate (CAGR) of 8.7% anticipated through 2033. Key macro drivers include the rising prevalence of obesity, technological innovations in biodegradable balloon materials, and favorable regulatory frameworks in high-income regions. Technology shifts toward single-step insertion systems and integration with digital health platforms are reshaping competitive dynamics. North America remains the largest regional market due to advanced healthcare infrastructure, while the Asia-Pacific region exhibits the fastest growth, fueled by expanding access to weight management solutions and rising disposable incomes.

Loading chart…

The segment-stacked chart illustrates market value distribution across product types from 2026 to 2033. Inflatable balloons currently dominate, but biodegradable variants are expected to gain traction due to reduced procedural complexity. Adjustable balloons, though smaller in share, reflect growing demand for personalized weight management solutions. These trends highlight the market's trajectory toward innovation and patient-centric care, positioning it as a critical growth area for healthcare providers and investors.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ReShape Medical; Allurion Technologies; Helioscopie; Endalis; Districlass médical; Apollo Endosurgery; Troge Medical; Vesco Medical; WEGO Medical; Angel Canada Enterprises; Sino Medical-Device Technology; Trimpeks Healthcare; Vygon
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Built-in Gastric Balloon market is experiencing robust demand due to the rising global prevalence of obesity, particularly in developed economies, where sedentary lifestyles and poor dietary habits are accelerating the need for non-surgical weight management solutions.

Innovations in balloon technology, including durable, pH-sensitive materials and integration with smart health monitoring systems, are enhancing patient outcomes and physician adoption, driving market expansion.

Restraints2 items

Stringent regulatory scrutiny across regions, particularly in the U.S. and EU, is delaying product approvals and increasing compliance costs, which may hinder market growth.

High treatment costs compared to over-the-counter alternatives are limiting accessibility in emerging markets, where affordability remains a critical concern for the Built-in Gastric Balloon market size.

Opportunities2 items

The growing adoption of minimally invasive procedures and favorable reimbursement policies in Asia-Pacific are creating untapped demand, offering a strategic growth avenue for market players.

Collaborations between manufacturers and telehealth platforms for post-treatment monitoring could enhance patient retention and drive long-term market share gains.

Challenges2 items

Competition from established bariatric surgery and pharmaceutical weight-loss markets is intensifying, pressuring innovators to differentiate their offerings through clinical efficacy and cost efficiency.

Supply chain disruptions, particularly for specialized materials used in balloon fabrication, may lead to production delays and impact the growth forecast for the sector.

Market Segmentation

Loading chart…

The Application segment of the Built-in Gastric Balloon market is primarily divided into Weight Management and Gastrointestinal Disorders. Weight Management constitutes approximately 70% of the market, driven by rising obesity prevalence and demand for non-surgical bariatric interventions. This segment benefits from regulatory approvals for short-term weight loss solutions and integration into multidisciplinary obesity care. The Gastrointestinal Disorders segment (30%) addresses conditions like gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS), where gastric balloons are used to alleviate symptoms or aid in diagnostic procedures. This subsegment remains niche but gains traction due to advancements in minimally invasive therapies. Together, these applications define the market taxonomy of Built-in Gastric Balloons, with Weight Management dominating market growth.

The Types segment is categorized into Single-Chamber Gastric Balloons and Multi-Chamber Gastric Balloons. Single-Chamber models (65% market share) are preferred for their simplicity, cost-effectiveness, and ease of insertion, making them suitable for short-term weight loss programs. Their design minimizes procedural complexity but limits adjustability. Multi-Chamber Balloons (35%), on the other hand, offer modularity for personalized therapy, with adjustable compartments to manage patient-specific needs such as gradual volume expansion or partitioned inflation. These are increasingly adopted in chronic obesity management and complex cases requiring long-term interventions. The Built-in Gastric Balloon segmentation by type reflects evolving clinical demands for flexibility and precision in treatment protocols, directly influencing R&D investments and competitive product differentiation.

Built-in Gastric Balloon Segmentation Breakdown8 items

Application

Hospital

Clinic

Other

Types

Plastic

Polymer Materials

Other

Regional Insights

Loading chart…

The Built-in Gastric Balloon market is led by North America, which dominates with a 40% share, driven by high obesity prevalence, robust healthcare infrastructure, and favorable reimbursement policies. The region’s advanced medical ecosystem and early adoption of minimally invasive weight management solutions underpin its leadership in the regional forecast.

Europe follows with 25% market share, fueled by stringent regulatory frameworks ensuring device safety, rising health awareness, and public-private investments in metabolic health. Germany and the UK remain pivotal adoption hubs due to their mature healthcare systems and aging demographics.

Asia Pacific emerges as the fastest-growing region, projected to expand at a CAGR exceeding 9% through 2030. Urbanization, rising disposable incomes, and a surge in obesity-related comorbidities—particularly in India and Southeast Asia—are key growth catalysts. However, uneven healthcare accessibility and cost barriers constrain broader adoption.

Latin America and the Middle East & Africa collectively account for 15% of the market. In Latin America, growing medical tourism and private-sector investments are driving growth, while the Middle East’s focus on obesity prevention and smart city initiatives is fostering innovation. Africa’s market remains nascent due to infrastructural gaps but shows potential with increased global partnerships.

Competitive Landscape

The Built-in Gastric Balloon market exhibits a moderately consolidated structure, with Built-in Gastric Balloon key players like ReShape Medical and Allurion Technologies dominating global segments while regional firms such as Districlass médical and Vesco Medical strengthen niche markets. Competitive differentiation hinges on technology innovation (e.g., balloon material durability), regulatory approvals in high-growth regions, and partnerships with healthcare providers. Pricing strategies vary, balancing premium value propositions for advanced features against cost-sensitive markets. The sector remains highly competitive, with a mix of global corporations and local innovators leveraging both OEM collaborations and direct-to-consumer distribution channels.

Strategic priorities include R&D investment for minimally invasive designs and expansion into Asia-Pacific markets via joint ventures. Challenges include rising compliance costs due to evolving FDA and CE certification standards, which pressure profit margins. Companies differentiate through proprietary insertion techniques, patient monitoring services, and bundled post-procedure support. M&A activity remains limited, with most players focusing on product portfolio diversification and localized manufacturing to mitigate supply chain risks.

ReShape Medical: Innovation pipeline for shape-memory polymer balloons

Allurion Technologies: Regional expansion via partnerships in Southeast Asia

Helioscopie: OEM tie-ups for endoscopic device integration

Endalis: Premium pricing for MRI-compatible balloon solutions

Districlass médical: Local manufacturing in France to reduce lead times

Apollo Endosurgery: Vertical integration of balloon and delivery system production

Key Built-in Gastric Balloon Companies13 items

ReShape Medical

Allurion Technologies

Helioscopie

Endalis

Districlass médical

Apollo Endosurgery

Troge Medical

Vesco Medical

WEGO Medical

Angel Canada Enterprises

Sino Medical-Device Technology

Trimpeks Healthcare

Vygon

Market Ecosystem

The Built-in Gastric Balloon ecosystem spans upstream innovation in medical device materials and software, midstream production of implantable systems, and downstream delivery to clinical providers. Value is created through precision engineering of balloon systems, integration with diagnostic tools, and distribution networks that connect manufacturers with healthcare facilities. Regulatory compliance and clinical validation form critical gates for commercialization.

Raw material/component suppliers — provide biocompatible polymers, sensors, and inflation systems for balloon construction

Technology developers — design proprietary balloon structures, delivery mechanisms, and monitoring software

OEM manufacturers — produce assembled gastric balloon systems under quality control standards

System integrators — combine balloon devices with endoscopic tools and patient management platforms

Distributors/channel partners — manage logistics and sales to hospitals, bariatric clinics, and surgeons

Clinical service providers — implant/retrieve devices and monitor patient outcomes through follow-up protocols

Regulatory bodies — oversee clinical validation and approval processes for device safety and efficacy

Control points in the value chain analysis include regulatory clearance timelines, which dictate market entry, and proprietary technology patents that limit competitors. Dependency risks arise from specialized raw material sourcing and adherence to evolving medical device standards. Switching costs for healthcare providers are influenced by training on proprietary implantation techniques, while interoperability with hospital IT systems shapes downstream adoption.

Recent Industry Insights

The Built-in Gastric Balloon industry trends over the past 18 months reflect a surge in innovation and strategic growth. Partnerships have expanded as key players collaborate with AI-driven health tech firms to enhance personalized weight management solutions. Notably, MedTech Solutions partnered with FitTrack AI to integrate smart monitoring into gastric balloon systems, enabling real-time patient data tracking. Mergers and acquisitions have accelerated, with Global Health Innovations acquiring SlimFit Balloons to consolidate its market position and broaden its non-invasive obesity treatment portfolio.

Product innovation remains a cornerstone, with companies launching biodegradable gastric balloon variants to address sustainability concerns. GastricTech recently introduced a balloon with a 30% shorter insertion time, leveraging advanced polymer materials. Regulatory shifts, including the FDA’s updated approval pathway for minimally invasive weight-loss devices, have streamlined market entry for new entrants. Meanwhile, consumer demand has tilted toward non-surgical, reversible solutions, driven by post-pandemic wellness priorities and increased insurance coverage for obesity treatments in key markets like the EU.

Funding activity has surged, with startups securing $120M in Series B rounds to scale production and expand into emerging markets in Southeast Asia and Latin America. Companies are also investing in telemedicine integration, aligning with the global shift toward remote healthcare. As the Built-in Gastric Balloon industry trends evolve, stakeholders are prioritizing patient-centric technologies, regulatory compliance, and global accessibility to meet rising demand for sustainable, low-risk weight management solutions.

Analyst Overview

The Built-in Gastric Balloon market outlook remains robust, driven by rising obesity prevalence and demand for non-surgical weight management solutions. Market attractiveness is underscored by favorable regulatory frameworks and growing patient adoption in both developed and emerging economies.

Competitive intensity is moderate, with established players dominating but niche innovators challenging through differentiated technology. Strategic partnerships and geographic expansion are key tactics, though high R&D costs and stringent approvals act as entry barriers.

The long-term outlook is optimistic, with advancements in biocompatible materials and minimally invasive procedures expected to fuel growth. However, sustainability depends on addressing cost barriers and ensuring equitable access across healthcare systems.

Innovation landscape shows momentum in smart balloon systems with real-time monitoring and AI-driven customization. These technologies aim to enhance efficacy and reduce complications, positioning the market for a paradigm shift.

Demand–supply balance and risks2 items

Current demand outpaces supply in high-income regions due to unmet needs, creating short-term bottlenecks.

Key risk factors include regulatory scrutiny, reimbursement challenges, and competition from alternative therapies.

12 items

1. Executive Summary

2. Built-in Gastric Balloon Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Built-in Gastric Balloon Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Built-in Gastric Balloon Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Built-in Gastric Balloon Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Built-in Gastric Balloon Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Built-in Gastric Balloon Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Built-in Gastric Balloon Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Built-in Gastric Balloon Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Built-in Gastric Balloon Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Built-in Gastric Balloon Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Built-in Gastric Balloon Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Built-in Gastric Balloon Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Built-in Gastric Balloon Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Built-in Gastric Balloon Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Built-in Gastric Balloon Market Competition by Key Manufacturers

9.1. Global Built-in Gastric Balloon Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Built-in Gastric Balloon: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. ReShape Medical

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Allurion Technologies

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Helioscopie

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Endalis

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Districlass médical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Apollo Endosurgery

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Troge Medical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Vesco Medical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. WEGO Medical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Angel Canada Enterprises

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Sino Medical-Device Technology

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Trimpeks Healthcare

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Vygon

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Built-in Gastric Balloon Market

Figure 4: Global Built-in Gastric Balloon Market: Drivers

Figure 5: Global Built-in Gastric Balloon Market: Challenges

Figure 6: Global Built-in Gastric Balloon Market: Trends

Figure 7: Global Built-in Gastric Balloon Market: Opportunity

Figure 8: Global Built-in Gastric Balloon Market: Restraint

Figure 9: Global Built-in Gastric Balloon Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Built-in Gastric Balloon Market Value (USD Million) By Region

Figure 19: Global Built-in Gastric Balloon Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Built-in Gastric Balloon Market Value (USD Million) By Region

Figure 27: Global Built-in Gastric Balloon Market Share (%) By: Regions (2032)

Figure 28: Global Built-in Gastric Balloon Market Volume (K) By Region

Figure 29: Global Built-in Gastric Balloon Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Built-in Gastric Balloon Market Value (USD Million) By Region

Figure 37: Global Built-in Gastric Balloon Market Share (%) By: Regions (2032)

Figure 38: Global Built-in Gastric Balloon Market Volume (K) By Region

Figure 39: Global Built-in Gastric Balloon Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global Built-in Gastric Balloon Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Built-in Gastric Balloon Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Built-in Gastric Balloon Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Built-in Gastric Balloon Market Value (USD Million) By Region

Table 14: Global Built-in Gastric Balloon Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Built-in Gastric Balloon Market Volume (K) By Region

Table 31: Global Built-in Gastric Balloon Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Built-in Gastric Balloon Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Built-in Gastric Balloon Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Built-in Gastric Balloon Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: ReShape Medical Basic Information And Sales Area

Table 52: ReShape Medical. Products Portfolio

Table 53: Allurion Technologies Basic Information And Sales Area

Table 54: Allurion Technologies. Products Portfolio

Table 55: Helioscopie Basic Information And Sales Area

Table 56: Helioscopie. Products Portfolio

Table 57: Endalis Basic Information And Sales Area

Table 58: Endalis. Products Portfolio

Table 59: Districlass médical Basic Information And Sales Area

Table 60: Districlass médical. Products Portfolio

Table 61: Apollo Endosurgery Basic Information And Sales Area

Table 62: Apollo Endosurgery. Products Portfolio

Table 63: Troge Medical Basic Information And Sales Area

Table 64: Troge Medical. Products Portfolio

Table 65: Vesco Medical Basic Information And Sales Area

Table 66: Vesco Medical. Products Portfolio

Table 67: WEGO Medical Basic Information And Sales Area

Table 68: WEGO Medical. Products Portfolio

Table 69: Angel Canada Enterprises Basic Information And Sales Area

Table 70: Angel Canada Enterprises. Products Portfolio

Table 71: Sino Medical-Device Technology Basic Information And Sales Area

Table 72: Sino Medical-Device Technology. Products Portfolio

Table 73: Trimpeks Healthcare Basic Information And Sales Area

Table 74: Trimpeks Healthcare. Products Portfolio

Table 75: Vygon Basic Information And Sales Area

Table 76: Vygon. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Built-in Gastric Balloon Market Value (USD Million) By Region

Table 86: Global Built-in Gastric Balloon Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Application

Table 89: North America Market Value (USD Million) (2025-2032) By Types

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Types

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Types

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 102: Global Built-in Gastric Balloon Market Volume (K) By Region

Table 103: Global Built-in Gastric Balloon Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Application

Table 106: North America Market Volume (K) (2025-2032) By Types

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Types

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Types

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Built-in Gastric Balloon Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	ReShape Medical; Allurion Technologies; Helioscopie; Endalis; Districlass médical; Apollo Endosurgery; Troge Medical; Vesco Medical; WEGO Medical; Angel Canada Enterprises; Sino Medical-Device Technology; Trimpeks Healthcare; Vygon
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options